Partner Interview
Published August 29, 2025
Rhode: Product Gaps, DTC-to-Retail Trade-Offs, and E.L.F. Integration Risk
inpractise.com/articles/rhode-product-gaps-dtc-to-retail-trade-offs-and-elf-integration-risk
Executive Bio
Former Executive at Rhode
Summary
Subscribe to access hundreds of interviews and primary research
Or contact sales for full access
Interview Transcript
Disclaimer: This interview is for informational purposes only and should not be relied upon as a basis for investment decisions. In Practise is an independent publisher and all opinions expressed by guests are solely their own opinions and do not reflect the opinion of In Practise.
This is a snippet of the transcript.to get full access.
My opinion always has to evolve. I'm trying to figure out why you bought a celebrity brand. Those things usually rise and fall with the celebrity's involvement. I definitely want to hear what you think about it.
For long-term growth in skincare, you need a catalog of products, which Rhode hasn't developed. With celebrity brands, like Hailey's, success isn't about her fans or Justin's fans buying the brand. It's about whether you and I buy it. I don't know if they can reach non-fans with their current strategy. I know about the turnover and legal issues they have, and it's not what I would want if I were at e.l.f. However, it could be a brand with a small chance of huge success, and maybe e.l.f., being cash-rich, decided to take that bet.
Free Sample of 50+ Interviews
Sign up to test our content quality with a free sample of 50+ interviews.
Or contact sales for full access
Related Content

e.l.f. Beauty: Rhode Acquisition Rationale & Integration
Former Director of Marketing and Product Development at NARS Cosmetics

E.L.F. Beauty: China Supply Chains, Margins, and Global Growth
Former Associate VP at e.l.f. Beauty

E.L.F. Beauty: Product Innovation & Distribution
Former Director of Product Development at e.l.f. Beauty

Aldevron & Synthetic DNA, Oracle, RBC Bearings, Hèrmes, Deere Parts, Equifax, Wolters Kluwer,
© 2024 In Practise. All rights reserved. This material is for informational purposes only and should not be considered as investment advice.